Skincare company Revision Skincare has released its D·E·J BioStim Treatment Solution designed for in-clinic use.
Available through aesthetic distributor AestheticSource, the treatment aims to stimulate the skin’s natural collagen and elastin production. AestheticSource notes that the treatment is a needle-free topical biostimulator, which uses a patent-pending, dual-action technology combining antioxidant phytoacids and a multi-acid delivery system to stimulate the dermal-epidermal junction, where skin firmness and elasticity originate.
The company further shares that it aims to support long-term skin health across the face, neck and décolletage.
Chief executive officer of AestheticSource, Lorna Bowes, commented, “Revision Skincare has built its reputation on combining cutting-edge science with clinically proven results, and this launch is another example of that commitment to innovation. It offers our clinic partners an exciting new way to deliver visible rejuvenation with minimal discomfort and downtime. We believe this treatment will become a valuable addition to any clinic looking to offer evidence-based solutions that support long-term skin health and skin longevity.